Response of Blood Pressure and Blood Glucose to Treatment With Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke | Zendy

Daniel M. Kerr | Zendy; Rachael L. Fulton | Zendy; Peter Higgins | Zendy; Philip M. Bath | Zendy; Ashfaq Shuaib | Zendy; Patrick D. Lyden | Zendy; Kennedy R. Lees | Zendy

Open Access

Response of Blood Pressure and Blood Glucose to Treatment With Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke

Author(s) -

Daniel M. Kerr,

Rachael L. Fulton,

Peter Higgins,

Philip M. Bath,

Ashfaq Shuaib,

Patrick D. Lyden,

Kennedy R. Lees

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.627059

Subject(s) - medicine , blood pressure , stroke (engine) , diabetes mellitus , tissue plasminogen activator , plasminogen activator , cardiology , diastole , t plasminogen activator , surgery , endocrinology , mechanical engineering , engineering

Elevations in blood pressure (BP) and blood glucose are common during stroke and may represent a stress response secondary to the acute neurological deficit. If so, they should settle more completely in recombinant tissue-type plasminogen activator (rtPA)-treated patients in association with improved neurological status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research